Doctors also struggle to get their patients prescriptions for these medications: according to Cure's specialty physician survey white paper, published in January, 89 percent faced coverage challenges when prescribing GLP-1s beyond obesity and diabetes
Importantly, tirzepatide powder forms are not FDA-approved for patient use, and reconstituting or using compounded versions carries significant health risks
The underlying price Medicare pays manufacturers will be about $245 per monthless than half the previous list price
Heres an overview of the most important things to remember about medical clearance: What dentists might not understand is that from a physicians perspective, medical clearance is based on different medical guidelines that dont account for dental surgery specifics like hemostatic control, osteonecrosis, or anesthetics
Skip to player Skip to main content Watch fullscreen Benzinga Ro's Supply Tracker Helps Patients Locate In-Demand GLP-1 Drugs Amid Shortages
